Hackensack Meridian Health announced the opening of its Institute for Multiple Myeloma, in partnership with pharmaceutical company Celgene, at the new Interprofessional Health Sciences Campus in Clifton and Nutley, earlier this week.
The former Roche campus also is the site of the hospital’s new School of Medicine at Seton Hall University. The institute has been anticipated for some time and represents the health system’s latest move to compete on a national level.
“This new center takes us a quantum leap forward in the fight against multiple myeloma and related illnesses,’’ HMH co-CEO Robert Garrett said. “This helps us achieve something that has been elusive — curing significant numbers of patients.’’ Read more here.